Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings

American Journal of Kidney Diseases

Volumn 44, Issue SUPPL. 2, 2004, Pages 27-33

  Locatelli, Francesco ^a   Pisoni, Ronald L ^b   Akizawa, Tadao ^c   Cruz, José M ^d   Deoreo, Peter B ^e   Lameire, Norbert H ^f   Held, Philip J ^g  

^a A MANZONI HOSPITAL   (Italy)

^b Univ Ren Res and Educ Assoc   (United States)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e Centers for Dialysis Care   (United States)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g MI 48103 ^*

Author keywords

Anemia; Dialysis Outcomes and Practice Patterns Study (DOPPS); erythropoietin; hemodialysis; hemoglobin; iron; mortality

Indexed keywords

HEMOGLOBIN;

ANEMIA; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; HEALTH CARE FACILITY; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INFORMATION PROCESSING; KIDNEY DISEASE; MEDICAL PRACTICE; MORBIDITY; OUTCOMES RESEARCH; PATIENT MONITORING; PRACTICE GUIDELINE; PUBLISHING; QUALITY OF LIFE; RENAL ANEMIA; REVIEW; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT OUTCOME;

EID: 5644295619     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.08.008     Document Type: Article

References (28)

1. F.K. Port, S.M. Orzol, P.J. Held Trends in treatment and survival for hemodialysis patients in the United States Am J Kidney Dis 32 suppl 4 1998 S34 S38
2. F. Locatelli, F. Conte, D. Marcelli The impact of hematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--The experience of the Lombardy Dialysis Registry Nephrol Dial Transplant 13 1998 1642 1644
3. A. Levin, C.R. Thompson, J. Ethier Left ventricular mass index increase in early renal disease Impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
4. R.N. Foley, P.S. Parfrey, J. Morgan Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy Kidney Int 58 2000 1325 1335
5. J.Z. Ma, J. Ebben, H. Xia, A.J. Collins Hematocrit level and associated mortality in hemodialysis patients J Am Soc Nephrol 10 1999 610 619
6. H. Xia, J. Ebben, J.Z. Ma Hematocrit levels and hospitalization risks in hemodialysis patients J Am Soc Nephrol 10 1999 1309 1316
7. B.C. Astor, P. Muntner, A. Levin Association of kidney function with anemia The Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408
8. A.J. Collins Influence of target hemoglobin in dialysis patients on morbidity and mortality Kidney Int Suppl 80 2002 44 48
9. L.P. McMahon, M.J. McKenna, T. Sangkabutra Physical performance and associated electrolyte changes after haemoglobin normalization A comparative study in hemodialysis patients Nephrol Dial Transplant 14 1999 1182 1187
10. P. Painter, G. Moore, L. Carlson Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life Am J Kidney Dis 39 2002 257 265
11. F. Moreno, D. Sanz-Guajardo, J.M. Lopez-Gomez Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients J Am Soc Nephrol 11 2000 335 342
12. D.S. Silverberg, D. Wexler, M. Blum The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol Dial Transplant 18 2003 141 146
13. E.W. Young, D.A. Goodkin, D.L. Mapes The Dialysis Outcomes and Practice Patterns Study (DOPPS) An international hemodialysis study Kidney Int Suppl 74 2000 S74 S81
14. H. Furuland, T. Linde, J. Ahlmen A randomized controlled trial of hemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients Nephrol Dial Transplant 18 2003 353 361
15. National Kidney Foundation K/DOQI Clinical Practice Guidelines. 2000 update Am J Kidney Dis 37 suppl 1 2001 S1 S238
16. European Best Practice Guidelines for the management of anemia in patients with chronic renal failure. Working Party for European Best Practices Guidelines for the Management of Anemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 14 suppl 5 1999 1 50
17. F. Locatelli, P. Aljama, P. Barany Revised European Best Practice Guidelines for the management of anemia in patients with chronic renal failure Nephrol Dial Transplant 19 suppl 2 2004 1 47
18. J.P. Vandenbroucke When are observational studies as credible as randomised trials? Lancet 363 2004 1728 1731
19. F. Locatelli, R.L. Pisoni, C. Combe Anemia in hemodialysis patients of five European Countries Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 2004 121 132
20. R.L. Pisoni, J.L. Bragg-Gresham, E.W. Young Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 2004 94 111
21. D.S. Harr, E.A. Balas, J. Mitchell Developing quality indicators as educational tools to measure the implementation of clinical practice guidelines Am J Med Qual 11 1996 179 185
22. A.S. Kliger, W.E. Haley Clinical practice guidelines in end-stage renal disease A strategy for implementation J Am Soc Nephrol 10 1999 872 877
23. J.M. Grimshaw, I.T. Russell Effect of clinical guidelines on medical practice A systematic review of rigorous evaluations Lancet 342 1993 1317 1322
24. C.R. Ramsay, M.K. Campbell, D. Cantarovich Evaluation of clinical guidelines for the management of end-stage renal disease in Europe The EU BIOMED 1 study Nephrol Dial Transplant 15 2000 1394 1398
25. F. Locatelli, S. Andrulli, L. Del Vecchio Difficulties of implementing clinical guidelines in medical practice Nephrol Dial Transplant 15 2000 1284 1287
26. D.A. Goodkin, J.L. Bragg-Gresham, K.G. Koenig Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States The Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 3270 3277
27. R.L. Pisoni, E.W. Young, D.M. Dykstra Vascular access use in Europe and the United States Results from the DOPPS Kidney Int 61 2002 305 316
28. F.K. Port, R.L. Pisoni, J.L. Bragg-Gresham DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States Blood Purif 22 2004 175 180